Meihua International Medical Technologies Co., Ltd. ("Meihua" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, announced today that the Company received a letter from the Nasdaq Stock Market LLC ("Nasdaq") on December 2, 2025, notifying the Company that the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the "Delisting Determination"), because the Company failed to regain compliance with the Nasdaq Listing Rule 5550(a)(2) (the "Rule").
Breaking News/EventRegulatory/Policy
Meihua International Medical Technologies Announces Nasdaq Staff Decision To Delist Shares
Benzinga•December 05, 2025 at 9:08 PM•Full Content
View Original →📊 Workflow Status
✓ CompletedCompleted in 2s
clean_raw_article
✓ completed→
clean_markdown_article
✓ completed→
analyze_article
✓ completed→
link_article_to_stories
⊘ skipped→
analyze_sentiment
⊘ skippedWorkflow #3565 • Benzinga Article Processing
Started: 21:09:00 • Completed: 21:09:02
View Details →Gist
Meihua International Medical Technologies received a Nasdaq delisting notice due to failure to regain compliance with minimum bid price requirements.
LLM Summary
Meihua International Medical Technologies (MHUA) was notified by Nasdaq on December 2, 2025, that its shares will be delisted from the Nasdaq Capital Market because it failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days, as required by Listing Rule 5550(a)(2). The company has the right to appeal the decision.
Full Article Content
Metadata
Author:
Benzinga Newsdesk
Tickers:
MHUA
Updated At:
December 05, 2025 at 5:08 PM
Benzinga Channels:
News
Teaser:
Meihua International Medical Technologies Co., Ltd. ("Meihua" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in
Benzinga Stocks:
MHUA (NASDAQ)
Benzinga Article ID:
49242349